By analyzing existing primary indicators between Lockheed Martin and Pfizer, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Pfizer with a short position in Lockheed Martin. Check out our
pair correlation module for more information.
Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lockheed Martin has an asset utilization ratio of 239.89 percent. This implies that the company is making $2.4 for each dollar of assets. An increasing asset utilization means that Lockheed Martin Corp is more efficient with each dollar of assets it utilizes for everyday operations.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two entities, such as Lockheed or Novocure is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.
understanding Lockheed Martin dividends
A dividend is the distribution of a portion of Lockheed Martin earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Lockheed Martin dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Lockheed one year expected dividend income is about USD6.92 per share.
At this time, Lockheed Martin's
Dividends Paid is comparatively stable compared to the past year.
Dividend Paid And Capex Coverage Ratio is likely to gain to 6.09 in 2024, whereas
Dividend Yield is likely to drop 0.02 in 2024.
Investing in dividend-paying stocks, such as Lockheed Martin is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Lockheed Martin must own a stock before its ex-dividend date to receive its next dividend.
This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Lockheed Martin. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.
How important is Lockheed Martin's Liquidity
Lockheed Martin
financial leverage refers to using borrowed capital as a funding source to finance Lockheed Martin ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Lockheed Martin financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Lockheed Martin's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Lockheed Martin's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Lockheed Martin's total debt and its cash.
Correlation Between Lockheed and Novocure
In general, Stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding Lockheed Martin together with similar or unrelated positions with a negative correlation. For example, you can also add Novocure to your portfolio. If Novocure is not perfectly correlated to Lockheed Martin it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When Lockheed Martin, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down.
Are you currently holding both Lockheed Martin and Novocure in your portfolio? Please note if you are using this as a pair-trade strategy between Lockheed Martin and Novocure, watch out for correlation discrepancy over time. Relying on the historical price correlations and assuming that it will not change may lead to short-term losses. Please check
pair correlation details between LMT and NVCR for more information.
Breaking it down
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Revenue Breakdown
Lets now check Lockheed Martin revenue. Based on the latest financial disclosure, Lockheed Martin Corp reported 64.72
B of revenue. This is much higher than that of the Industrials sector and significantly higher than that of the
Aerospace & Defense industry. The revenue for all United States stocks is significantly lower than that of the stock. As for Pfizer we see revenue of 99.88
B, which is much higher than that of the Aerospace & Defense
| Lockheed | 64.72 Billion |
| Sector | 3.5 Billion |
| Pfizer | 99.88 Billion |
Will Lockheed Martin recuperate in December?
The jensen alpha is down to 0.12 as of today. Lockheed Martin Corp has relatively low volatility with skewness of 0.82 and kurtosis of 6.33. However, we advise all investors to independently investigate Lockheed Martin Corp to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lockheed Martin's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lockheed Martin's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Final Take On Lockheed Martin
Whereas some other companies in the aerospace & defense industry are either recovering or due for a correction, Lockheed may not be as strong as the others in terms of longer-term growth potentials. While some private investors may not share our view, we believe that right now is not a good time to increase your holdings in Lockheed. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Lockheed Martin.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Lockheed Martin. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
